Middle East News Digest
SEE OTHER BRANDS

Your daily news update on the Middle East

Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on August 30, 2025

Gideon Group CEO Salman Z. Khan Publishes LinkedIn Analysis on AI’s Impact on Mid-Level Roles

Gideon Group CEO Salman Z. Khan Publishes LinkedIn Analysis on AI’s Impact on Mid-Level Roles

Gideon Group CEO Salman Z. Khan shares a LinkedIn article examining AI’s effect on mid-level workforce roles and organizational structures. AZ, UNITED STATES, August 30, 2025 /⁨EINPresswire.com⁩/ -- Salman Z. Khan, CEO of The Gideon Group, has published a …

Dubai-Based MKV Luxury Introduces Zero-Deposit Option in Supercar Rentals

Dubai-Based MKV Luxury Introduces Zero-Deposit Option in Supercar Rentals

MKV Luxury: Redefining the Way Dubai Drives in Style DUBAI, DUBAI, UNITED ARAB EMIRATES, August 30, 2025 /⁨EINPresswire.com⁩/ -- In the city where luxury is a lifestyle, MKV Luxury Car Rental Dubai has quickly established itself as one of Dubai’s most …

KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients

KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients

RIYADH, Saudi Arabia, Aug. 30, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …

Ceyone Launches 'Only Villas' — India’s First Digital Platform Exclusively for Villa Buyers

Ceyone Launches 'Only Villas' — India’s First Digital Platform Exclusively for Villa Buyers

Only Villas by Ceyone is India’s first digital platform dedicated to villa buyers, offering curated listings and a seamless buying experience. BANGALORE, KARNATAKA, INDIA, August 30, 2025 /⁨EINPresswire.com⁩/ -- First-time villa buyers, apartment …

Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension

Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension

- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM outcomes for patients with ATTR-CM - Acoramidis also demonstrated a significant 46% hazard …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions